Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ophthotech Corp (NASDAQ:OPHT)

2.97
Delayed Data
As of Apr 28
 +0.07 / +2.41%
Today’s Change
2.70
Today|||52-Week Range
65.96
-38.51%
Year-to-Date
No recent news for Ophthotech Corp.

Today’s Trading

Previous close2.90
Today’s open2.92
Day’s range2.87 - 2.98
Volume691,676
Average volume (3 months)1,470,162
Market cap$106.5M
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-78.10%
Earnings growth (this year)+30.70%
Earnings growth (next 5 years)--
Revenue growth (last year)-1.16%
P/E ratioNM
Price/Sales3.37
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CRMECardiome Pharma Corp+0.02+0.60%
VVUSVIVUS Inc-0.02-1.94%
ARLZAralez Pharmaceutica...-0.02-1.23%
INFIInfinity Pharmaceuti...+0.05+2.38%
Data as of 4:14pm ET, 04/28/2017

Financials

Next reporting dateMay 16, 2017
EPS forecast (this quarter)-$1.31
Annual revenue (last year)$50.9M
Annual profit (last year)-$193.4M
Net profit margin-379.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
David R. Guyer
President, Chief Financial Officer &
Treasurer
Glenn P. Sblendorio
Corporate headquarters
New York, New York

Forecasts